We engage ethically with all providers, and do so transparently and in compliance with country laws, regulations and trade association obligations.
AbbVie supports disclosure and transparency on interactions between the healthcare industry and healthcare professionals to ensure public trust and confidence.
In alignment with the member companies of Medicines Australia, AbbVie has undertaken to be open and transparent when we provide a reportable payment to a healthcare professional or a third party as directed by a healthcare professional. Reportable payments or transfers of value are:
AbbVie has prepared the report for publication in accordance with the Medicines Australia Code of Conduct, Edition 20 and Australia’s Privacy legislation. The report identifies healthcare professionals by name where their consent has been provided. Where consent has not been provided, the information is reported in aggregate.
From 1 October 2016, reporting of these payments is mandatory.
The report is designed to be read on this website. It is also provided as a downloadable CSV file.
To comply with our privacy obligations, the report may be amended from time to time. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.
For further information about the details in the report, please go to https://www.medicinesaustralia.com.au/code/transparency-reporting/payments-to-healthcare-professionals/
This report will be available for at least three years from the date of publication.
AbbVie collaborates and co-creates with the groups working with and representing patients. The grants we provide patient groups to support their ongoing work can be found here.
AbbVie engages with the Australian Government to participate, as appropriate, in ongoing discussions on the healthcare environment, including access to medicines and healthcare reform. AbbVie contributes to these by sharing global knowledge, insights, and safety and efficacy data, as appropriate, on relevant therapies. AbbVie does not provide cash donations to political parties in Australia. As part of our engagement with Government we attend and occasionally sponsor political events and roundtable discussions where public policy on the healthcare environment is discussed.
In 2023, our expenditure in attending political events was:
| Labor: | $15,000 |
| Coalition: | $13,636 |
| Total: | $28,636 |
In 2024, our expenditure in attending political events was:
| Labor: | $15,000 |
| Coalition: | $13,636 |
| Total: | $28,636 |
In 2025, our expenditure in attending political events was:
| Labor: | $15,000 |
| Coalition: | $13,636 |
| Total: | $28,636 |
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?